KLSE:HSPLANT Statistics
Total Valuation
KLSE:HSPLANT has a market cap or net worth of MYR 1.50 billion. The enterprise value is 942.86 million.
Market Cap | 1.50B |
Enterprise Value | 942.86M |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | Mar 12, 2025 |
Share Statistics
KLSE:HSPLANT has 799.69 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 799.69M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 1.06% |
Owned by Institutions (%) | 9.58% |
Float | 214.24M |
Valuation Ratios
The trailing PE ratio is 7.35 and the forward PE ratio is 9.50.
PE Ratio | 7.35 |
Forward PE | 9.50 |
PS Ratio | 2.00 |
PB Ratio | 0.71 |
P/TBV Ratio | 0.71 |
P/FCF Ratio | 10.56 |
P/OCF Ratio | 7.18 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.65, with an EV/FCF ratio of 6.62.
EV / Earnings | 4.61 |
EV / Sales | 1.25 |
EV / EBITDA | 2.65 |
EV / EBIT | 3.48 |
EV / FCF | 6.62 |
Financial Position
The company has a current ratio of 12.89, with a Debt / Equity ratio of 0.03.
Current Ratio | 12.89 |
Quick Ratio | 10.42 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.18 |
Debt / FCF | 0.45 |
Interest Coverage | 85.58 |
Financial Efficiency
Return on equity (ROE) is 10.09% and return on invested capital (ROIC) is 8.09%.
Return on Equity (ROE) | 10.09% |
Return on Assets (ROA) | 6.74% |
Return on Invested Capital (ROIC) | 8.09% |
Return on Capital Employed (ROCE) | 10.72% |
Revenue Per Employee | 94,434 |
Profits Per Employee | 25,682 |
Employee Count | 8,046 |
Asset Turnover | 0.30 |
Inventory Turnover | 4.39 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.73% in the last 52 weeks. The beta is 0.05, so KLSE:HSPLANT's price volatility has been lower than the market average.
Beta (5Y) | 0.05 |
52-Week Price Change | +2.73% |
50-Day Moving Average | 1.93 |
200-Day Moving Average | 1.88 |
Relative Strength Index (RSI) | 44.69 |
Average Volume (20 Days) | 361,950 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:HSPLANT had revenue of MYR 752.45 million and earned 204.64 million in profits. Earnings per share was 0.26.
Revenue | 752.45M |
Gross Profit | 307.49M |
Operating Income | 270.94M |
Pretax Income | 267.78M |
Net Income | 204.64M |
EBITDA | 330.14M |
EBIT | 270.94M |
Earnings Per Share (EPS) | 0.26 |
Balance Sheet
The company has 624.20 million in cash and 63.65 million in debt, giving a net cash position of 560.55 million or 0.70 per share.
Cash & Cash Equivalents | 624.20M |
Total Debt | 63.65M |
Net Cash | 560.55M |
Net Cash Per Share | 0.70 |
Equity (Book Value) | 2.10B |
Book Value Per Share | 2.63 |
Working Capital | 805.87M |
Cash Flow
In the last 12 months, operating cash flow was 209.48 million and capital expenditures -67.09 million, giving a free cash flow of 142.39 million.
Operating Cash Flow | 209.48M |
Capital Expenditures | -67.09M |
Free Cash Flow | 142.39M |
FCF Per Share | 0.18 |
Margins
Gross margin is 40.87%, with operating and profit margins of 36.01% and 27.20%.
Gross Margin | 40.87% |
Operating Margin | 36.01% |
Pretax Margin | 35.59% |
Profit Margin | 27.20% |
EBITDA Margin | 43.88% |
EBIT Margin | 36.01% |
FCF Margin | 18.92% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 6.61%.
Dividend Per Share | 0.13 |
Dividend Yield | 6.61% |
Dividend Growth (YoY) | 83.82% |
Years of Dividend Growth | n/a |
Payout Ratio | 26.57% |
Buyback Yield | n/a |
Shareholder Yield | 6.61% |
Earnings Yield | 13.61% |
FCF Yield | 9.47% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
KLSE:HSPLANT has an Altman Z-Score of 3.86.
Altman Z-Score | 3.86 |
Piotroski F-Score | n/a |